CVS will shut down clin­i­cal tri­als unit that it launched dur­ing Covid

CVS Health is shut­ting down the clin­i­cal tri­als busi­ness that it launched just two years ago, part of an ef­fort to fo­cus on its core busi­ness.

CVS con­firmed the move in a state­ment:  “We con­tin­u­al­ly eval­u­ate our port­fo­lio of as­sets to en­sure they are aligned with our long-term strate­gic pri­or­i­ties,” a spokesman for the com­pa­ny said in a text. “We’re wind­ing down our Clin­i­cal Tri­al Ser­vices busi­ness in a phased way, with a full ex­it ex­pect­ed by De­cem­ber 31, 2024.”

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN